相似文献
1
Treatment of oral dryness related complaints (xerostomia) in Sjögren's syndrome.
Ann Rheum Dis. 1999 Aug;58(8):465-74. doi: 10.1136/ard.58.8.465.
2
Optimizing dry mouth treatment for individuals with Sjögren's syndrome.
Rheum Dis Clin North Am. 2008 Nov;34(4):1001-10, x. doi: 10.1016/j.rdc.2008.08.013.
3
Diagnosis and management of the dry mouth: Part 1.
Dent Update. 1996 Mar;23(2):56-62.
4
The association between oral dryness and use of dry-mouth interventions in Sjögren's syndrome patients.
Clin Oral Investig. 2022 Feb;26(2):1465-1475. doi: 10.1007/s00784-021-04120-2. Epub 2021 Aug 10.
5
[Xerostomia and means that facilitate its symptoms].
Stomatologiia (Mosk). 2013;92(5):12-3.
6
Sialendoscopy increases saliva secretion and reduces xerostomia up to 60 weeks in Sjögren's syndrome patients: a randomized controlled study.
Rheumatology (Oxford). 2021 Mar 2;60(3):1353-1363. doi: 10.1093/rheumatology/keaa284.
7
Treatment of xerostomia in Sjögren's syndrome - what effect does it have on the oral microbiome?
Front Cell Infect Microbiol. 2025 Apr 14;15:1484951. doi: 10.3389/fcimb.2025.1484951. eCollection 2025.
8
Xerostomia: diagnosis and treatment.
Am J Otolaryngol. 1983 Jul-Aug;4(4):283-92. doi: 10.1016/s0196-0709(83)80072-6.
9
Management of xerostomia and other complications of Sjögren's syndrome.
Oral Maxillofac Surg Clin North Am. 2014 Feb;26(1):63-73. doi: 10.1016/j.coms.2013.09.010.
10
Sjögren's syndrome -- managing oral and systemic symptoms via a multi-disciplinary approach.
Oral Dis. 2004 Sep;10(5):306-9. doi: 10.1111/j.1601-0825.2004.00991.x.
引用本文的文献
1
The Oral Microbial Ecosystem in Age-Related Xerostomia: A Critical Review.
Int J Mol Sci. 2024 Nov 28;25(23):12815. doi: 10.3390/ijms252312815.
2
The Yin and Yang of Sodium Lauryl Sulfate Use for Oral and Periodontal Health: A Literature Review.
J Dent (Shiraz). 2023 Sep;24(3):262-276. doi: 10.30476/dentjods.2022.95108.1836.
3
An Overview of the Dry Eye Disease in Sjögren's Syndrome Using Our Current Molecular Understanding.
Int J Mol Sci. 2023 Jan 13;24(2):1580. doi: 10.3390/ijms24021580.
4
A Review on Xerostomia and Its Various Management Strategies: The Role of Advanced Polymeric Materials in the Treatment Approaches.
Polymers (Basel). 2022 Feb 22;14(5):850. doi: 10.3390/polym14050850.
5
Medication-Induced Xerostomia and Hyposalivation in the Elderly: Culprits, Complications, and Management.
Drugs Aging. 2018 Oct;35(10):877-885. doi: 10.1007/s40266-018-0588-5.
6
World Workshop on Oral Medicine VI: a systematic review of medication-induced salivary gland dysfunction: prevalence, diagnosis, and treatment.
Clin Oral Investig. 2015 Sep;19(7):1563-80. doi: 10.1007/s00784-015-1488-2. Epub 2015 May 22.
7
Diagnosis and management of xerostomia and hyposalivation.
Ther Clin Risk Manag. 2014 Dec 22;11:45-51. doi: 10.2147/TCRM.S76282. eCollection 2015.
8
The protein kinase A pathway contributes to Hg2+-induced alterations in phosphorylation and subcellular distribution of occludin associated with increased tight junction permeability of salivary epithelial cell monolayers.
J Pharmacol Exp Ther. 2008 Sep;326(3):829-37. doi: 10.1124/jpet.107.135798. Epub 2008 Jun 12.
9
The efficacy of Xialine in patients with Sjögren's syndrome: a single-blind, cross-over study.
Clin Oral Investig. 2008 Jun;12(2):165-72. doi: 10.1007/s00784-007-0159-3. Epub 2007 Nov 14.
10
Xerostomia secondary to Sjögren's syndrome in the elderly: recognition and management.
Drugs Aging. 2005;22(11):887-99. doi: 10.2165/00002512-200522110-00001.
本文引用的文献
1
Antimalarial ocular toxicity a critical appraisal.
J Clin Rheumatol. 1998 Apr;4(2):57-62. doi: 10.1097/00124743-199804000-00004.
2
Periodontal health in patients with rheumatoid arthritis: comment on the article by Kässer et al.
Arthritis Rheum. 1998 Nov;41(11):2081-3. doi: 10.1002/1529-0131(199811)41:11<2081::AID-ART26>3.0.CO;2-D.
3
Efficacy of a synthetic polymer saliva substitute in reducing oral complaints of patients suffering from irradiation-induced xerostomia.
Quintessence Int. 1998 Jun;29(6):383-8.
4
Oral pilocarpine for symptomatic relief of dry mouth and dry eyes in patients with Sjögrens syndrome.
Adv Exp Med Biol. 1998;438:973-8. doi: 10.1007/978-1-4615-5359-5_139.
5
Oral candidiasis and Sjögren's syndrome.
J Rheumatol. 1998 May;25(5):911-5.
6
Oral manifestations in patients with Sjögren's syndrome.
J Rheumatol. 1998 May;25(5):906-10.
7
A double blind placebo controlled trial of azathioprine in the treatment of primary Sjögren's syndrome.
J Rheumatol. 1998 May;25(5):896-9.
8
Single-blinded controlled trial of low-dose oral IFN-alpha for the treatment of xerostomia in patients with Sjögren's syndrome.
J Interferon Cytokine Res. 1998 Apr;18(4):255-62. doi: 10.1089/jir.1998.18.255.
9
Advances in the pathogenesis of periodontitis: summary of developments, clinical implications and future directions.
Periodontol 2000. 1997 Jun;14:216-48. doi: 10.1111/j.1600-0757.1997.tb00199.x.
10
Antifungal therapy in the oral cavity.
Periodontol 2000. 1996 Feb;10:89-106. doi: 10.1111/j.1600-0757.1996.tb00070.x.
Zotero 插件